Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis.
Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study.
Atopic eczema and fracture risk in adults: A population-based cohort study.
Ten years change in post-fracture care for hip fracture patients.
Muscular Fitness Mediates the Association between 25-Hydroxyvitamin D and Areal Bone Mineral Density in Children with Overweight/Obesity.
Assessment on patient outcomes of primary hip replacement: an interrupted time series analysis from ‘The National Joint Registry of England and Wales’.
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.
Vitamin D, menopause, and aging: quo vadis? Climacteric.
Prevalence and mortality of individuals with X-linked hypophosphataemia: a United Kingdom real world data analysis.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
